Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
37 studies found for:    " August 29, 2012":" September 28, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Active, not recruiting Rapid Initiation of Antiretroviral Therapy to Promote Early HIV/AIDS Treatment in South Africa (RapIT Study)
Condition: HIV
Intervention: Other: Rapid ART initiation
22 Unknown  A Pilot Study to Assess the Feasibility of Switching, Individuals Receiving Atripla With Continuing Central Nervous System (CNS) Toxicity, to a Fixed Dose Combination of Tenofovir/Emtricitabine/Rilpivirine
Condition: HIV
Intervention: Drug: tenofovir/emtricitabine/rilpivirine
23 Recruiting Management of Highly Active Anti-retroviral Therapy-related Hyperlipidemia Among HIV-infected Patients in Taiwan
Condition: HIV
Intervention:
24 Completed A Study to Assess Cerebrospinal Fluid INflammatory Markers After Addition of Maraviroc to MONotherapy Darunavir/Ritonavir - The CINAMMON Study
Condition: HIV
Intervention: Drug: maraviroc
25 Terminated ER Niacin/Laropiprant Impact on Cardiovascular Markers and Atheroprogression in HIV-infected Individuals on cART
Conditions: HIV;   Atherosclerosis
Interventions: Drug: niacin/laropiprant;   Drug: Placebo
26 Completed Safety and Efficacy of the PrePex Device Circumcision When Performed by Nurses
Conditions: Circumcision Adult;   HIV CDC Category B2
Intervention: Device: PrePex™ device
27 Completed
Has Results
Safety Sudy of Atazanavir Boosted With Ritonavir in the Treatment of HIV Infection in Pediatric Patients
Condition: HIV, Pediatric
Interventions: Drug: Atazanavir;   Drug: Ritonavir
28 Withdrawn A Study on the Safety and Effectiveness of Rilpivirine Hydrochloride (Edurant) Among Adult Filipino Patients With Human Immunodeficiency Virus Type-I Infection
Condition: Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Intervention: Drug: No intervention
29 Recruiting Pharmacokinetics of Anti-TB Drugs in HIV/TB Co-infected Children in Ghana
Conditions: Tuberculosis;   HIV
Intervention:
30 Recruiting Brain Imaging for HIV-Associated Thinking and Mood Disorders
Conditions: Human Immunodeficiency Virus;   Neurocognitive Impairment
Intervention:
31 Unknown  Pharmacokinetic Study of Pitavastatin and Ritonavir-Boosted Darunavir or Efavirenz
Conditions: Hyperlipidemia;   HIV
Interventions: Drug: Pitavastatin;   Drug: Darunavir;   Drug: Ritonavir;   Drug: Efavirenz
32 Completed Benefits and Costs of Integrating Sexual-Reproductive Health and HIV Services in Kenya and Swaziland
Conditions: Pregnancy;   HIV
Intervention: Procedure: Integrated FP/PNC service delivery
33 Completed Vacc-4x + Lenalidomide vs. Vacc-4x +Placebo in HIV-1-infected Subjects on Antiretroviral Therapy (ART)
Condition: HIV-1 Infection
Interventions: Drug: Part A: lenalidomide dose escalation;   Drug: Part B: lenalidomide;   Drug: Part B: lenalidomide placebo
34 Recruiting Rifampin and Nevirapine Interactions in Young Children
Conditions: Tuberculosis;   HIV
Intervention:
35 Completed A Phase 2a Study of Simtuzumab in HIV and/or Hepatitis C- Infected Subjects With Liver Fibrosis
Conditions: Liver Fibrosis;   Hepatitis C;   HIV;   HIV/HCV Co-infection
Intervention: Biological: Simtuzumab
36 Completed A Phase II Trial to Assess the Safety and Immunogenicity of DNA Priming Administered by the ID Zetajet® With or Without ID Derma Vax™ Electroporation Followed by IM MVA Boosting in Healthy Volunteers in Tanzania and Mozambique
Conditions: Vaccines;   HIV;   Safety;   Immunogenicity
Interventions: Biological: HIVIS DNA vaccine;   Device: Zetajet;   Device: Derma Vax Electroporation;   Biological: Modified Vaccinia Ankara (MVA-CDMR)
37 Recruiting Protect and Connect: Couple HIV Prevention for Drug Involved Male Offenders
Conditions: Sexually Transmitted Diseases;   Unsafe Sex;   Substance-Related Disorders
Interventions: Behavioral: PACT;   Behavioral: TAU

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-37) Next Page   
Study has passed its completion date and status has not been verified in more than two years.